Hello. Unfortunately, no medicine in our country has been approved by health institutions. Evrysdi has recently received FDA approval and we very much hope it will work better due to its cheaper price and less hassle. So far, Brazil, Japan and the United States have issued licenses, and the drug will likely be available in the next few months. The European Union is also considering the drug.
Hairy movement milestones in pediatric patients, one year after treatment with Evrysdi(Residiplam)
https://ibb.co/QCx5Cm1